We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
TIDMGWP
RNS Number : 1831Y
GW Pharmaceuticals PLC
19 February 2013
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 17 AUGUST 2012 TO: 18 FEBRUARY 2013
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
272,088 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
NIL ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
272,088 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
200,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
133,370,354 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 17 AUGUST 2012 TO: 18 FEBRUARY 2013
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
127,067 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
NIL ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
127,067 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
500,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
133,370,354 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME
3. PERIOD OF RETURN:
FROM: 17 AUGUST 2012 TO: 18 FEBRUARY 2013
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
349,600 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
NIL ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
349,600 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003
300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008
400,000 ORDINARY SHARES OF 0.1P EACH ON 18 JANUARY 2010
400,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
300,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
133,370,354 ORDINARY SHARES OF 0.1P EACH
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS LONG TERM INCENTIVE PLAN 2008
3. PERIOD OF RETURN:
FROM: 17 AUGUST 2012 TO: 18 FEBRUARY 2013
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
435,000 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
25,000 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
410,000 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
600,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
133,370,354 ORDINARY SHARES OF 0.1P EACH
For further information, please contact:
Adam George, Company Secretary, GW Pharmaceuticals plc
Telephone: +44 (0)1980 557000
James Steel/Vijay Barathan, Nominated Adviser, Peel Hunt LLP
Telephone: +44 (0)20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRKKLBFXLFLBBK
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
